Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 4
2019 1
2020 4
2021 5
2022 7
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Strategies for Radioiodine Treatment: What's New.
Sparano C, Moog S, Hadoux J, Dupuy C, Al Ghuzlan A, Breuskin I, Guerlain J, Hartl D, Baudin E, Lamartina L. Sparano C, et al. Among authors: moog s. Cancers (Basel). 2022 Aug 4;14(15):3800. doi: 10.3390/cancers14153800. Cancers (Basel). 2022. PMID: 35954463 Free PMC article. Review.
[Succinate dehydrogenase in cancer].
Moog S, Favier J. Moog S, et al. Med Sci (Paris). 2022 Mar;38(3):255-262. doi: 10.1051/medsci/2022024. Epub 2022 Mar 25. Med Sci (Paris). 2022. PMID: 35333162 Free article. French.
CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype.
de Zélicourt A, Fayssoil A, Dakouane-Giudicelli M, De Jesus I, Karoui A, Zarrouki F, Lefebvre F, Mansart A, Launay JM, Piquereau J, Tarragó MG, Bonay M, Forand A, Moog S, Piétri-Rouxel F, Brisebard E, Chini CCS, Kashyap S, Fogarty MJ, Sieck GC, Mericskay M, Chini EN, Gomez AM, Cancela JM, de la Porte S. de Zélicourt A, et al. Among authors: moog s. EMBO Mol Med. 2022 May 9;14(5):e12860. doi: 10.15252/emmm.202012860. Epub 2022 Mar 17. EMBO Mol Med. 2022. PMID: 35298089 Free PMC article.
New endpoints in adrenocortical carcinoma studies: a mini review.
Faron M, Lamartina L, Hescot S, Moog S, Deschamps F, Roux C, Libe R, Durand-Labrunie J, Al Ghuzlan A, Hadoux J, Baudin E. Faron M, et al. Among authors: moog s. Endocrine. 2022 Sep;77(3):419-424. doi: 10.1007/s12020-022-03128-2. Epub 2022 Jul 23. Endocrine. 2022. PMID: 35869971 Review.
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma.
Hadoux J, Al Ghuzlan A, Lamartina L, Bani MA, Moog S, Attard M, Scoazec JY, Hartl D, Aldea M, Friboulet L, Jules-Clement G, Italiano A, Besse B, Lacroix L, Baudin E. Hadoux J, et al. Among authors: moog s. JCO Precis Oncol. 2023 Sep;7:e2300053. doi: 10.1200/PO.23.00053. JCO Precis Oncol. 2023. PMID: 38127829
Preclinical evaluation of targeted therapies in Sdhb-mutated tumors.
Moog S, Salgues B, Braik-Djellas Y, Viel T, Balvay D, Autret G, Robidel E, Gimenez-Roqueplo AP, Tavitian B, Lussey-Lepoutre C, Favier J. Moog S, et al. Endocr Relat Cancer. 2022 May 11;29(6):375-388. doi: 10.1530/ERC-22-0030. Endocr Relat Cancer. 2022. PMID: 35348472
24 results